✦ LIBER ✦

Responsiveness of the Motor Function Measure in Patients With Spinal Muscular Atrophy

✍ Scribed by Vuillerot, Carole; Payan, Christine; Iwaz, Jean; Ecochard, René; Bérard, Carole

Book ID: 120984224
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 184 KB
Volume: 94
Category: Article
ISSN: 1532-821X
DOI: 10.1016/j.apmr.2013.01.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

M.P.2.08 Use of the motor function measu

M.P.2.08 Use of the motor function measure to assess motor function in patients with spinal muscular atrophy

✍ C. Vuillerot; C. Payan; C. Bérard 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

N.P.4 02 Motor function measure that per

N.P.4 02 Motor function measure that permits the evaluation of ambulatory spinal muscular atrophy patients

✍ J.M. Rascoll; A.M. Glanzman; S. Riley; J. Quigley; J. Flickinger; P. Ryan; M. Mc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 43 KB

The gross motor function measure™ is a v

The gross motor function measure™ is a valid and sensitive outcome measure for spinal muscular atrophy

✍ Leslie Nelson; Hollis Owens; Linda S. Hynan; Susan T. Iannaccone; AmSMART Group 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Masticatory muscle function in patients

Masticatory muscle function in patients with spinal muscular atrophy

✍ M.W. Granger; P.H. Buschang; G.S. Throckmorton; S.T. Iannaccone 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 28 KB

Hybrid survival motor neuron genes in Ja

Hybrid survival motor neuron genes in Japanese patients with spinal muscular atrophy

✍ H. Nishio; H. Horikawa; H. Yakura; K. Sugie; T. Nakamuro; K. Koterazawa; Y. Ishi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 837 KB

Compound muscle action potential and mot

Compound muscle action potential and motor function in children with spinal muscular atrophy

✍ Aga Lewelt; Kristin J. Krosschell; Charles Scott; Ai Sakonju; John T. Kissel; Th 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

## Abstract Reliable outcome measures that reflect the underlying disease process and correlate with motor function in children with SMA are needed for clinical trials. Maximum ulnar compound muscle action potential (CMAP) data were collected at two visits over a 4–6‐week period in children with SM